Patents Assigned to ARTHROSI THERAPEUTICS, INC.

Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

Patent number: 11236058

Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.

Type: Grant

Filed: November 14, 2019

Date of Patent: February 1, 2022

Assignee: ARTHROSI THERAPEUTICS, INC.

Inventors: Shunqi Yan, Li-Tain Yeh, Robert Orr
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

Patent number: 10508093

Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.

Type: Grant

Filed: February 5, 2019

Date of Patent: December 17, 2019

Assignee: ARTHROSI THERAPEUTICS, INC.

Inventors: Shunqi Yan, Li-Tain Yeh, Robert Orr
Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

Patent number: 10239854

Abstract: The inventive subject matter provides compounds, compositions and methods for lowering serum acid (sUA) for the treatment of gout, and having reduced liver toxicity, associated with CYP2C9 metabolic pathway.

Type: Grant

Filed: October 4, 2018

Date of Patent: March 26, 2019

Assignee: ARTHROSI THERAPEUTICS, INC.

Inventors: Shunqi Yan, Li-Tain Yeh, Robert Orr

Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia

Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia